RECRUITING

Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the study is to learn about the best way to enhance pharmacy-related care for diabetes self-management. This research is being done because we want to improve use of medicines and diabetes management among adults with type 2 diabetes and find out which of type of support may improve diabetes self-management for adults. Participants will be assigned to one of 4 groups, and will either: * receive care as usual; or, * receive added medicine management support from a pharmacist; or, * receive support from a Community Health Worker (CHW) to address life challenges; or, * receive both the pharmacist medicine management and the CHW support

Official Title

A Multiphase Optimization Strategy to Enhance Diabetes Management Interventions for Patients With Uncontrolled Diabetes

Quick Facts

Study Start:2024-02-03
Study Completion:2027-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05912647

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Men and women ages 18-90 with diagnosed type 2 diabetes who speak and understand English or Spanish.
  2. * Taking at least one oral or injectable diabetes medication
  3. * HbA1c ≥ 8% based on point of care test.
  4. * Will reside in the geographical area throughout the study period.
  5. * Have access to a phone during the study period.
  6. * Willing to attend all orientation/training sessions.
  1. * Having a caregiver who is the main decision maker in self-management.
  2. * Participating in another lifestyle, or medication adherence program.
  3. * Participated in standard MTM/MTM-related intervention in the last 6 months.

Contacts and Locations

Study Contact

Martha Maurer
CONTACT
608-265-2662
mamaurer@wisc.edu

Principal Investigator

Michelle Chui, PharmD, PhD
PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison

Study Locations (Sites)

University of Wisconsin
Madison, Wisconsin, 53705
United States

Collaborators and Investigators

Sponsor: University of Wisconsin, Madison

  • Michelle Chui, PharmD, PhD, PRINCIPAL_INVESTIGATOR, University of Wisconsin, Madison

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-02-03
Study Completion Date2027-12

Study Record Updates

Study Start Date2024-02-03
Study Completion Date2027-12

Terms related to this study

Additional Relevant MeSH Terms

  • Diabetes
  • Diabetes Type 2